Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-13

Clinical Trial Update: Selegiline for Smoking Cessation - 1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating selegiline for smoking cessation; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selegiline (selegiline)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Nicotine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2016-10-13